Intrastriatal gradient analyses of 18F-FDOPA PET scans for differentiation of Parkinsonian disorders

Intrastriatal gradient analyses of 18F-FDOPA PET scans for differentiation of Parkinsonian disorders

Aim: L -3,4-dihydroxy-6–18F-fluorophenylalanine (18F-DOPA PET may be used to distinguish subjects with Parkinsonism from those with symptoms not originating from impaired dopaminergic transmission. However, it is not routinely utilized to discriminate Idiopathic Parkinson's disease (IPD) from A...

Full description

Bibliographic Details
Main Authors:	Gilles N. Stormezand, Lumi T. Chaves, David Vállez García, Janine Doorduin, Bauke M. De Jong, Klaus L. Leenders, Berry P.H. Kremer, Rudi A.J.O. Dierckx
Format:	Article
Language:	English
Published:	Elsevier 2020-01-01
Series:	NeuroImage: Clinical
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213158219305078

Similar Items

Incidental meningioma detected with [18F]-FDOPA PET/CT
by: Gilles N. Stormezand, et al.
Published: (2018-11-01)

Feasibility of pharmacokinetic parametric PET images in scaled subprofile modelling using principal component analysis
by: Débora E. Peretti, et al.
Published: (2021-01-01)

The effects of molar activity on [18F]FDOPA uptake in patients with neuroendocrine tumors
by: Gilles N. Stormezand, et al.
Published: (2021-09-01)

Altered Regional Cerebral Blood Flow in Chronic Whiplash Associated Disorders
by: David Vállez García, et al.
Published: (2016-08-01)

Brain Evaluation by Dual PET/CT with [<sup>18</sup>F] FDOPA and [<sup>18</sup>F] FDG in Differential Diagnosis of Parkinsonian Syndromes
by: Fabio Andrés Sinisterra Solís, et al.
Published: (2024-09-01)

A standardized method for the construction of tracer specific PET and SPECT rat brain templates: validation and implementation of a toolbox.
by: David Vállez Garcia, et al.
Published: (2015-01-01)

Additive Value of Dynamic FDOPA PET/CT for Glioma Grading
by: Antoine Girard, et al.
Published: (2021-07-01)

Correction: A Standardized Method for the Construction of Tracer Specific PET and SPECT Rat Brain Templates: Validation and Implementation of a Toolbox.
by: David Vállez Garcia, et al.
Published: (2015-01-01)

Comparison of [18F]-FDOPA PET and [123I]-FP-CIT SPECT acquired in clinical practice for assessing nigrostriatal degeneration in patients with a clinically uncertain parkinsonian syndrome
by: Elon Wallert, et al.
Published: (2022-10-01)

Continued Presence of Intrastriatal but not Intraventricular Polymer-Encapsulated PC12 Cells is Required for Alleviation of Behavioral Deficits in Parkinsonian Rodents
by: Dwaine F. Emerich, et al.
Published: (1996-09-01)

18F-FDOPA PET/CT accurately identifies MEN1-associated pheochromocytoma
by: Aisha A Tepede, et al.
Published: (2020-03-01)

[18F]FDOPA PET/CT is superior to [68Ga]DOTATOC PET/CT in diagnostic imaging of pheochromocytoma
by: Peter Iversen, et al.
Published: (2023-12-01)

TCH346 prevents motor symptoms and loss of striatal FDOPA uptake in bilaterally MPTP-treated primates
by: Gerda Andringa, et al.
Published: (2003-11-01)

Complex Diagnostic Challenges in Glioblastoma: The Role of <sup>18</sup>F-FDOPA PET Imaging
by: David Sipos, et al.
Published: (2024-09-01)

FDOPA-(18F): a PET radiopharmaceutical recently registered for diagnostic use in countries of the European Union
by: Yanna-Marina Chevalme, et al.
Published: (2007-09-01)

Usefulness of 18F-FDOPA PET for the management of primary brain tumors: a systematic review of the literature
by: François Somme, et al.
Published: (2020-10-01)

Dynamic 18F-FDopa PET Imaging for Newly Diagnosed Gliomas: Is a Semiquantitative Model Sufficient?
by: Timothée Zaragori, et al.
Published: (2021-10-01)

Comparing [18F]FET PET and [18F]FDOPA PET for glioma recurrence diagnosis: a systematic review and meta-analysis
by: Pengbo Yu, et al.
Published: (2024-01-01)

Impact of non-uniform attenuation correction in a dynamic [18F]-FDOPA brain PET/MRI study
by: Jorge Cabello, et al.
Published: (2019-08-01)

Increased dopamine D2/D3 receptor and serotonin transporter availability in male rats after spontaneous remission from repeated social defeat-induced depression; a PET study in rats
by: Rodrigo Moraga-Amaro, et al.
Published: (2024-11-01)

Diagnostic performance of regional cerebral blood flow images derived from dynamic PIB scans in Alzheimer’s disease
by: Débora E. Peretti, et al.
Published: (2019-07-01)

Optimization of time frame binning for FDOPA uptake quantification in glioma.
by: Antoine Girard, et al.
Published: (2020-01-01)

Therapeutic efficacy of AAV8-mediated intrastriatal delivery of human cerebral dopamine neurotrophic factor in 6-OHDA-induced parkinsonian rat models with different disease progression.
by: Lizheng Wang, et al.
Published: (2017-01-01)

The impact of 18F-FDOPA-PET/MRI image fusion in detecting liver metastasis in patients with neuroendocrine tumors of the gastrointestinal tract
by: O. Barachini, et al.
Published: (2020-02-01)

Prognostic value of 11C-methionine volume-based PET parameters in IDH wild type glioblastoma.
by: Bart R J van Dijken, et al.
Published: (2022-01-01)

Changes in pancreatic levodopa uptake in patients with obesity and new-onset type 2 diabetes: an 18F-FDOPA PET-CT study
by: Yeongkeun Kwon, et al.
Published: (2025-03-01)

Early acquisition of [18F]FDOPA PET/CT imaging in patients with recurrent or residual medullary thyroid cancer is safe—and slightly better!
by: Mette Louise Gram Kjærulff, et al.
Published: (2022-08-01)

Striatal dopamine synthesis capacity in autism spectrum disorder and its relation with social defeat: an [18F]-FDOPA PET/CT study
by: Rik Schalbroeck, et al.
Published: (2021-01-01)

Alzheimer’s disease pattern derived from relative cerebral flow as an alternative for the metabolic pattern using SSM/PCA
by: Débora E. Peretti, et al.
Published: (2022-06-01)

Evaluation of Intraperitoneal [18F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis Capacity
by: Els F. Halff, et al.
Published: (2022-01-01)

Optimizing the radiosynthesis of 6-[F-18]FDOPA using [F-18]Selectfluor
by: Forsback, S, et al.
Published: (2013)

PET Imaging of Astrogliosis and Tau Facilitates Diagnosis of Parkinsonian Syndromes
by: Sonja Schönecker, et al.
Published: (2019-09-01)

Relative cerebral flow from dynamic PIB scans as an alternative for FDG scans in Alzheimer's disease PET studies.
by: Débora E Peretti, et al.
Published: (2019-01-01)

Correction: Relative cerebral flow from dynamic PIB scans as an alternative for FDG scans in Alzheimer's disease PET studies.
by: Débora E Peretti, et al.
Published: (2019-01-01)

Mitigation of noise-induced bias of PET radiomic features.
by: Ananthi Somasundaram, et al.
Published: (2022-01-01)

[18F] FDOPA PET may confirm the clinical diagnosis of Parkinson's disease by imaging the nigro-striatal pathway and the sympathetic cardiac innervation: Proof-of-concept study
by: Jonathan Kuten, Adi Linevitz, Hedva Lerman, Nanette Freedman, Meir Kestenbaum, Tamara Shiner, Nir Giladi, Einat Even-Sapir
Published: (2020-09-01)

Serotonergic system in vivo with [11C]DASB PET scans in GTP-cyclohydrolase deficient dopa-responsive dystonia patients
by: Elze R. Timmers, et al.
Published: (2022-04-01)

Relation of 18-F-Dopa PET with hypokinesia-rigidity, tremor and freezing in Parkinson’s disease
by: Angelina R.A. Pikstra, et al.
Published: (2016-01-01)

Paeonol Protection Against Intrastriatal 6-Hydroxydopamine Rat Model of Parkinson\'s Disease
by: Jamileh Ghalami, et al.
Published: (2021-01-01)

Better Outcomes with Intranigral versus Intrastriatal Cell Transplantation: Relevance for Parkinson’s Disease
by: Marine Droguerre, et al.
Published: (2022-04-01)